United States - december, 16, 2021:Paxlovid, Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study
Choose your region
Selecting a region may change the language and promotional content you see on the Adobe Stock web site.